Price information and purchasing guide for cartegravir sodium tablets

Cabotegravir sodium tablets (cabotegravir), as an innovative HIV-1 integrase strand transfer inhibitor (INSTI), has been available since 2021 year1< /span>Since it was approved by the US Food and Drug Administration (FDA) on March 21, it has provided a new option for the treatment and prevention of HIV-1 infection. In my country, cartegravir sodium tablets were officially launched in July 2023 under the trade name Wankairui.

Categravir sodium tablets are mainly used for the short-term treatment of HIV-1 infection in adults and adolescents aged 12 years and above who weigh at least 35kg. It is specifically indicated for patients with stable virologic suppression, a stable antiretroviral regimen, no history of treatment failure, and no known or suspected resistance to cabotegravir or rilpivirine. In addition, cartegravir sodium tablets are also suitable for short-term pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection due to sexual behavior. Before starting HIV-1 PrEP with castegravir sodium tablets, the individual must have an HIV-1 test and confirm that the result is negative.

Categravir sodium tablets work by reducing the amount of HIV in the blood. Although it does not completely cure HIV, it can effectively reduce the risk of acquired immunodeficiency syndrome (AIDS) and HIV-related diseases (such as serious infections or cancer). At the same time, along with safe sex and other lifestyle changes, canegravir sodium tablets can also help reduce the risk of transmitting the HIV virus to others.

Regarding price and purchasing channels, there is currently no generic version of canegravir sodium tablets on the market. The price of the European version of the original drug is about RMB 8,000. However, this drug is currently not included in medical insurance and may pose a certain financial burden to patients. For patients in need of medication, they can consult local hospital pharmacies or regular overseas medical consulting agencies to obtain medication information. When purchasing, patients should make sure to choose formal channels and follow the doctor's advice and guidance to ensure the safety and effectiveness of the medication.

In general, cartegravir sodium tablets provide a new option for the treatment and prevention of HIV-1 infection. However, patients should fully understand its indications, mechanism of action, efficacy, price, purchase channels and other information before taking the drug, and use it rationally under the guidance of a doctor.

Reference link: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212887s008lbl.pdf